Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Quality control plan for a primary bladder neoplastic process].

Cristóbal Marchal Escalona1, Miguel Padilla León, Javier García Penit

  • 1Area Integrada de Gestión de Urología-Diálisis, Hospital Costa del Sol. Marbella, Málaga, España. cmarchal@inicia.es

Archivos Espanoles De Urologia
|May 7, 2003
PubMed
Summary

Implementing quality control in bladder cancer care significantly reduced treatment delays. This systematic approach improved patient outcomes by streamlining diagnosis and surgical intervention timelines, enhancing overall management efficiency.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Testicular epidermoid cyst: A rare entity].

Archivos espanoles de urologia·2015
Same author

Spontaneous hemoperitoneum secondary to retroperitoneal tumor rupture.

Archivos espanoles de urologia·2014
Same author

Thirteen centimeter subcapsular haematoma in a patient with thoraco-abdominal aortic aneurysm and mural thrombus.

Archivos espanoles de urologia·2014
See all related articles

Area of Science:

  • Urology
  • Oncology
  • Healthcare Management

Context:

  • Bladder cancer diagnosis and treatment delays can negatively impact patient survival rates.
  • Effective quality control is crucial for optimizing the management of primary bladder cancer.
  • This study evaluated delays and implemented improvements in a real-world clinical setting.

Purpose:

  • To apply a quality control plan to manage primary bladder cancer, focusing on identifying and reducing diagnostic and treatment delays.
  • To analyze global and individual indicators of delay in bladder cancer care.
  • To assess the impact of implemented improvement measures on reducing these delays.

Summary:

  • A retrospective chart review identified significant delays in bladder cancer treatment, with average global delays of 208.3 days.

Related Experiment Videos

  • Variability was noted in times for transurethral resection (1-73.42 days) and postoperative revision (54.4 days).
  • Implemented quality control measures reduced average global delays to 134.2 days and postoperative revision variability to 32.4 days.

    • Impact:

    • Quality control procedures are essential for systematic, continuous, and rigorous evaluation in clinical practice.
    • Improvements in management efficiency can lead to better patient satisfaction and outcomes.
    • This approach provides a framework for enhancing the quality of care in urological oncology.